Phase 1 N=35 Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Driving Impaired
Primary: Standard Deviation of Lateral Position (SDLP) — 29.3; 29.7; 38.6 cm of deviation of lateral position
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=33 Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
Psoriasis Vulgaris
Primary: The Adrenal Response to the ACTH Challenge Test Defined as the Serum Cortisol Concentration Obtained After 30 and 60 Minutes — 29; 1 Participants
Phase 2 N=476 A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
Osteoarthritis, Hip · Osteoarthritis, Knee · Arthritis
Primary: Change From Baseline at Week 8 With Respect to the Weekly Mean of the Daily 24-hour Pain Intensity for the Index Joint as Measured by the Numeric Rating Scale (NRS)…
Phase 2 N=50 Rasagiline Rescue in Alzheimer's Disease Clinical Trial
Alzheimer's Disease
Primary: Change in Regional Glucose Metabolism Between Week 24 and Baseline as Measured by 18F-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography (FDG-PET). — -0.032…
N/A N=50 Connected Healthcare for Individuals Living at Home With Chronic Conditions
Medication Adherence · Medication Compliance · Medication Nonadherence
Primary: Recorded Medication Adherence — 98.35; 91.17 percentage of medication adherence — p=<0.01
N/A N=60 Effect of Group Led Creative Writing on Mood in Cancer Patients
Cancer Patients
Primary: Emotional Thermometer Subscale 1- Distress at Final — 0; 1.5 units on a scale
N/A N=30 Comparison of E-health vs. In-person Multi-Family Group (MFG)
Schizophrenia · Schizoaffective Disorder · Schizophrenia and Related Disorders
Primary: Goal Attainment Scale — 6.25; 14.29; 37.5; 0 percentage of participats — p=0.3749
N/A N=25 Pilot Evaluation of the Empower Neuromodulation System in AUD Patients
Alcohol Use Disorder
Primary: Change in Mean Number of Alcoholic Drinks Consumed Per Day — -1.1 Change in alcoholic drinks per day — p=0.026
Phase 3 N=46 Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
Bipolar Disorder
Primary: YMRS — 10; 18.82; 4.29 score on a scale
N/A N=165 Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty
Arthroplasty, Replacement, Knee · Nerve Block
Primary: Morphine Equivalents — 11.9; 12.5; 96.5; 73.9 milligrams of morphine
N/A N=11 Desaturation Validation of INVSENSOR00037
Healthy
Primary: Trending Accuracy of the INVSENSOR00037 — 1.8 percentage of regional oxygen saturation
Phase 4 N=65 Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain
Pain, Radiating
Primary: Avoidance of Neck Surgery — 24; 20; 3; 6 Participants
N/A N=9 Effects of Obesity Surgery on Renal Function
Impaired Renal Function
Primary: Changes in Glomerular Renal Function After Weight Loss Surgery as Measured by 51Cr-EDTA Clearance — 0 Participants
Phase 3 N=923 Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue
Dengue Fever
Primary: Geometric Mean Titers (GMTs) of Neutralizing Antibodies for Each of the 4 Dengue Serotypes at Day 120 in the Immunogenicity Subset — 5.3; 202.9; 293.8; 322.1 titer
Phase 1 N=31 Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer
Neoplasm
Primary: Best Overall Tumor Response Following Administration of CS-7017 in Participants With Advanced or Metastatic Malignancies — 0; 0; 0; 0 Participants